These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24763838)

  • 21. Prevention of inappropriate ICD shocks in patients with Brugada syndrome.
    Veltmann C; Kuschyk J; Schimpf R; Streitner F; Schoene N; Borggrefe M; Wolpert C
    Clin Res Cardiol; 2010 Jan; 99(1):37-44. PubMed ID: 19760052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-degree atrioventricular block on basal electrocardiogram predicts future arrhythmic events in patients with Brugada syndrome: a long-term follow-up study from the Veneto region of Northeastern Italy.
    Migliore F; Testolina M; Zorzi A; Bertaglia E; Silvano M; Leoni L; Bellin A; Basso C; Thiene G; Allocca G; Delise P; Iliceto S; Corrado D
    Europace; 2019 Feb; 21(2):322-331. PubMed ID: 29986018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up in patients with Brugada Syndrome in South China.
    Zhao D; Liang B; Peng J; Tang L; Su R; Luo L; Deng B; Wang S
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12823. PubMed ID: 33417270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.
    Delise P; Allocca G; Marras E; Giustetto C; Gaita F; Sciarra L; Calo L; Proclemer A; Marziali M; Rebellato L; Berton G; Coro L; Sitta N
    Eur Heart J; 2011 Jan; 32(2):169-76. PubMed ID: 20978016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.
    Steinfurt J; Biermann J; Bode C; Odening KE
    Dtsch Arztebl Int; 2015 Jun; 112(23):394-401. PubMed ID: 26157012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
    van der Werf C; Lieve KV; Bos JM; Lane CM; Denjoy I; Roses-Noguer F; Aiba T; Wada Y; Ingles J; Leren IS; Rudic B; Schwartz PJ; Maltret A; Sacher F; Skinner JR; Krahn AD; Roston TM; Tfelt-Hansen J; Swan H; Robyns T; Ohno S; Roberts JD; van den Berg MP; Kammeraad JA; Probst V; Kannankeril PJ; Blom NA; Behr ER; Borggrefe M; Haugaa KH; Semsarian C; Horie M; Shimizu W; Till JA; Leenhardt A; Ackerman MJ; Wilde AA
    Eur Heart J; 2019 Sep; 40(35):2953-2961. PubMed ID: 31145795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study.
    Rodríguez-Mañero M; Baluja A; Hernández J; Muñoz C; Calvo D; Fernández-Armenta J; García-Fernández A; Zorio E; Arce-León Á; Sánchez-Gómez JM; Mosquera-Pérez I; Arias MÁ; Díaz-Infante E; Expósito V; Jiménez-Ramos V; Teijeira E; Cañadas-Godoy MV; Guerra-Ramos JM; Oloriz T; Basterra N; Sousa P; Elices-Teja J; García-Bolao I; González-Juanatey JR; Brugada R; Gimeno JR; Brugada J; Arbelo E
    Rev Esp Cardiol (Engl Ed); 2022 Jul; 75(7):559-567. PubMed ID: 34479845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome.
    Dendramis G; Brugada P
    Heart Rhythm; 2023 Feb; 20(2):274-281. PubMed ID: 36162769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brugada syndrome and syncope: a practical approach for diagnosis and treatment.
    Mascia G; Bona RD; Ameri P; Canepa M; Porto I; Parati G; Crotti L; Brignole M
    Europace; 2021 Jul; 23(7):996-1002. PubMed ID: 33367713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up.
    El-Battrawy I; Roterberg G; Liebe V; Ansari U; Lang S; Zhou X; Borggrefe M; Akin I
    Clin Cardiol; 2019 Oct; 42(10):958-965. PubMed ID: 31441080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P; Faria B; Dias G; Cardoso F; Alves MJ; Alves A; Rodrigues B; Ribeiro S; Sanfins V; Lourenço A
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):33-38. PubMed ID: 33436324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of spontaneous type I ECG pattern, syncope, and other risk markers in sudden cardiac arrest survivors with Brugada syndrome.
    Leong KMW; Ng FS; Jones S; Chow JJ; Qureshi N; Koa-Wing M; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Lim PB; Peters NS; Kanagaratnam P; Varnava AM
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):257-264. PubMed ID: 30569504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M
    Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome.
    El-Battrawy I; Roterberg G; Schlentrich K; Liebe V; Lang S; Rudic B; Tülümen E; Zhou X; Borggrefe M; Akin I
    Pediatr Cardiol; 2020 Feb; 41(2):290-296. PubMed ID: 31748893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G; Silva E; Bisbal F; Viola G; Merella P; Lorenzoni G; Motta G; Bandino S; Berne P
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.
    Rodríguez-Mañero M; Sacher F; de Asmundis C; Maury P; Lambiase PD; Sarkozy A; Probst V; Gandjbakhch E; Castro-Hevia J; Saenen J; Fukushima Kusano K; Rollin A; Arbelo E; Valderrábano M; Arias MA; Mosquera-Pérez I; Schilling R; Chierchia GB; García-Bolao I; García-Seara J; Hernandez-Ojeda J; Kamakura T; Martínez-Sande L; González-Juanatey JR; Haïssaguerre M; Brugada J; Brugada P
    Heart Rhythm; 2016 Mar; 13(3):669-82. PubMed ID: 26538325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.